Cargando…
The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model
BACKGROUND: Glioblastomas are largely unresponsive to all available treatments and there is therefore an urgent need for novel therapeutics. Here we have probed the antineoplastic effects of a bacterial protein toxin, the cytotoxic necrotizing factor 1 (CNF1), in the syngenic GL261 glioma cell model...
Autores principales: | Vannini, Eleonora, Panighini, Anna, Cerri, Chiara, Fabbri, Alessia, Lisi, Simonetta, Pracucci, Enrico, Benedetto, Nicola, Vannozzi, Riccardo, Fiorentini, Carla, Caleo, Matteo, Costa, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075618/ https://www.ncbi.nlm.nih.gov/pubmed/24939046 http://dx.doi.org/10.1186/1471-2407-14-449 |
Ejemplares similares
-
Bacterial Toxins and Targeted Brain Therapy: New Insights from Cytotoxic Necrotizing Factor 1 (CNF1)
por: Tantillo, Elena, et al.
Publicado: (2018) -
Escherichia coli Cytotoxic Necrotizing Factor 1 (CNF1): Toxin Biology, in Vivo Applications and Therapeutic Potential
por: Fabbri, Alessia, et al.
Publicado: (2010) -
Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stages
por: Vannini, Eleonora, et al.
Publicado: (2017) -
CTX-CNF1 Recombinant Protein Selectively Targets Glioma Cells In Vivo
por: Vannini, Eleonora, et al.
Publicado: (2021) -
The bacterial toxin CNF1 as a tool to induce retinal degeneration reminiscent of retinitis pigmentosa
por: Guadagni, Viviana, et al.
Publicado: (2016)